Investor Relations
Changing the Future

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests and that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Learn More

Latest News
Loading...
Stock Information
NASDAQCODX
Events
Thursday, August 11, 2022
4:30pm - 5:30pm EDT

Co-Diagnostics, Inc. Q2 2022 Earnings Webcast

Sunday, July 24, 2022 - Thursday, July 28, 2022

Co-Dx will be hosting a booth to showcase its existing and upcoming suite of diagnostics products and technology applications at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo, held...

All Events